ZA931597B - Neurotrophic factors having altered receptor binding specificities. - Google Patents
Neurotrophic factors having altered receptor binding specificities.Info
- Publication number
- ZA931597B ZA931597B ZA931597A ZA931597A ZA931597B ZA 931597 B ZA931597 B ZA 931597B ZA 931597 A ZA931597 A ZA 931597A ZA 931597 A ZA931597 A ZA 931597A ZA 931597 B ZA931597 B ZA 931597B
- Authority
- ZA
- South Africa
- Prior art keywords
- neurotrophic factors
- receptor binding
- binding specificities
- altered receptor
- bind
- Prior art date
Links
- 108010025020 Nerve Growth Factor Proteins 0.000 title abstract 4
- 102000007072 Nerve Growth Factors Human genes 0.000 title abstract 4
- 239000003900 neurotrophic factor Substances 0.000 title abstract 4
- 108020003175 receptors Proteins 0.000 title abstract 3
- 102000005962 receptors Human genes 0.000 title abstract 3
- 108091008604 NGF receptors Proteins 0.000 abstract 1
- 102000007339 Nerve Growth Factor Receptors Human genes 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/48—Nerve growth factor [NGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Prostheses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/847,369 US5349055A (en) | 1992-03-06 | 1992-03-06 | Nerve growth factor having altered receptor binding specificities |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA931597B true ZA931597B (en) | 1993-09-27 |
Family
ID=25300448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA931597A ZA931597B (en) | 1992-03-06 | 1993-03-05 | Neurotrophic factors having altered receptor binding specificities. |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US5349055A (da) |
| EP (1) | EP0632817B1 (da) |
| JP (1) | JP3694523B2 (da) |
| CN (1) | CN1041831C (da) |
| AT (1) | ATE219500T1 (da) |
| AU (1) | AU674305B2 (da) |
| CA (1) | CA2131552A1 (da) |
| DE (1) | DE69332047T2 (da) |
| DK (1) | DK0632817T3 (da) |
| ES (1) | ES2178641T3 (da) |
| IL (1) | IL104958A0 (da) |
| WO (1) | WO1993018066A1 (da) |
| ZA (1) | ZA931597B (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8017894A (en) * | 1993-10-18 | 1995-05-08 | Regeneron Pharmaceuticals, Inc. | Growth factor heterodimers |
| US5753225A (en) * | 1993-12-03 | 1998-05-19 | The Regents Of The University Of California | Antibodies that mimic actions of neurotrophins |
| US5728803A (en) * | 1994-06-03 | 1998-03-17 | Genentech, Inc. | Pantropic neurotrophic factors |
| US7144983B1 (en) | 1997-02-03 | 2006-12-05 | Genentech, Inc. | Pantropic neurotrophic factors |
| US5958875A (en) * | 1996-03-29 | 1999-09-28 | The Regents Of The University Of California | Synthetic peptides derivatives with nerve growth factor-like neurotrophic activity |
| GB9608335D0 (en) * | 1996-04-23 | 1996-06-26 | Univ Kingston | Method of enhancing ngf-mediated neurite growth with low molecular weight analoues of p.75 ngfr 367-379 |
| AU720232B2 (en) | 1996-07-19 | 2000-05-25 | Amgen, Inc. | Analogs of cationic proteins |
| CN1268639C (zh) | 1996-11-15 | 2006-08-09 | 基因技术股份有限公司 | 神经营养蛋白的纯化 |
| CN101260398B (zh) * | 2007-03-07 | 2013-06-05 | 舒泰神（北京）生物制药股份有限公司 | 神经生长因子基因定位改造动物及其制备方法和应用 |
| CN102898514B (zh) * | 2011-07-28 | 2015-04-29 | 中国人民解放军军事医学科学院生物工程研究所 | 重组人神经生长因子缺失突变体及其制备方法和用途 |
| CN103880944B (zh) * | 2014-01-20 | 2017-03-29 | 未名生物医药有限公司 | 一种野生型rhNGF的制备方法 |
| US11883464B2 (en) * | 2016-03-18 | 2024-01-30 | Staidson (Beijing) Biopharmaceuticals Co., Ltd. | Nerve growth factor fusion protein, preparation method and use thereof |
-
1992
- 1992-03-06 US US07/847,369 patent/US5349055A/en not_active Expired - Lifetime
-
1993
- 1993-03-05 ZA ZA931597A patent/ZA931597B/xx unknown
- 1993-03-05 IL IL104958A patent/IL104958A0/xx unknown
- 1993-03-06 CN CN93104050A patent/CN1041831C/zh not_active Expired - Fee Related
- 1993-03-08 DK DK93905743T patent/DK0632817T3/da active
- 1993-03-08 AU AU36550/93A patent/AU674305B2/en not_active Ceased
- 1993-03-08 CA CA002131552A patent/CA2131552A1/en not_active Abandoned
- 1993-03-08 WO PCT/SE1993/000201 patent/WO1993018066A1/en active IP Right Grant
- 1993-03-08 DE DE69332047T patent/DE69332047T2/de not_active Expired - Fee Related
- 1993-03-08 EP EP93905743A patent/EP0632817B1/en not_active Expired - Lifetime
- 1993-03-08 ES ES93905743T patent/ES2178641T3/es not_active Expired - Lifetime
- 1993-03-08 AT AT93905743T patent/ATE219500T1/de not_active IP Right Cessation
- 1993-03-08 JP JP51559493A patent/JP3694523B2/ja not_active Expired - Fee Related
-
1994
- 1994-09-02 US US08/300,044 patent/US5705617A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CN1041831C (zh) | 1999-01-27 |
| JP3694523B2 (ja) | 2005-09-14 |
| DE69332047D1 (de) | 2002-07-25 |
| EP0632817A1 (en) | 1995-01-11 |
| AU3655093A (en) | 1993-10-05 |
| AU674305B2 (en) | 1996-12-19 |
| DK0632817T3 (da) | 2002-12-23 |
| IL104958A0 (en) | 1993-07-08 |
| JPH08511675A (ja) | 1996-12-10 |
| US5349055A (en) | 1994-09-20 |
| ATE219500T1 (de) | 2002-07-15 |
| US5705617A (en) | 1998-01-06 |
| EP0632817B1 (en) | 2002-06-19 |
| CA2131552A1 (en) | 1993-09-16 |
| CN1079992A (zh) | 1993-12-29 |
| ES2178641T3 (es) | 2003-01-01 |
| WO1993018066A1 (en) | 1993-09-16 |
| DE69332047T2 (de) | 2003-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL104958A0 (en) | Neurotrophic factors having altered receptor binding specificities | |
| TW332784B (en) | Preparing method for catalyst composition | |
| GR3032161T3 (en) | Amido siladiyl bridged catalyst components, methods of making and using | |
| EP0484043A3 (en) | Translation of midi files | |
| GR3025668T3 (en) | New crystalline form of a vitamin d analogue. | |
| AU2790384A (en) | Preparation of synthetic hydrocarbons | |
| AU4920393A (en) | Iron making process using petroleum coke | |
| AU4349385A (en) | Liquefaction of gases | |
| CA2224974A1 (en) | Composite particulate material and process for preparing same | |
| IL92737A0 (en) | Cloning and expression of transforming growth factor beta-2 | |
| HU9303200D0 (en) | Metalchelate-binding antibody-polipeptides with modified affinity | |
| GB8411096D0 (en) | Control of air-fuel ratio | |
| TW326470B (en) | Water dispersion of emulsion-graftpolymer used as binders of textile and leather | |
| EP0334464A3 (en) | Tension leg joint | |
| AU2350092A (en) | Process for the preparation of hydrocarbon fuels | |
| GB9016270D0 (en) | Process for reducing the metal content of a hydrocarbon mixture | |
| AU3379089A (en) | Bitumen composition | |
| EP0368343A3 (en) | Ameliorating composition for dysmnesia | |
| AU650981B2 (en) | Coal-water mixture using upgraded low-rank coal and process for producing said mixture | |
| EP0149486A3 (en) | Detergent composition and gasoline composition containing same | |
| AU2193092A (en) | Super glucocorticoid receptors: receptors with increased affinity and specificity for glucocorticoid steroids | |
| GB2230843B (en) | Gaseous mixture control | |
| AU564567B2 (en) | Liquefaction of coal | |
| MX9606720A (es) | Polipeptidos con dominios de enlace al receptor 1 de la interleucina 8(il8r1). | |
| GB8815622D0 (en) | Process & installation for preparation of hydrocarbons |